[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366523-105":59,"doc-detail-366523-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-gut-microbiome-in-lung-cancer-from-pathogenesis-to-precision-therapy","The gut microbiome in lung cancer - from pathogenesis to precision therapy","","The review synthesizes current evidence linking the gut microbiome to lung cancer biology, emphasizing the gut-lung axis as a bidirectional network that connects intestinal microbes with pulmonary immune and metabolic pathways. It highlights how gut dysbiosis can contribute to tumor development and influence responses to immune checkpoint inhibitors, including mechanisms involving tumor microenvironment immunology and microbial-immune crosstalk. The work also discusses microbial biomarkers and microbiota-targeted interventions to support precision, personalized lung cancer management.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-gut-microbiome-in-lung-cancer-from-pathogenesis-to-precision-therapy/366523/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-gut-microbiome-in-lung-cancer-from-pathogenesis-to-precision-therapy/366523.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the gut-lung axis and why is it relevant to lung cancer?","Question",{"text":112,"@type":113},"The gut-lung axis is described as a bidirectional network connecting intestinal microbiota with pulmonary physiology through immune, neural, and metabolic pathways, enabling systemic immunomodulatory effects relevant to lung cancer development and treatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How can gut dysbiosis affect immunotherapy outcomes in lung cancer?",{"text":117,"@type":113},"The document links gut dysbiosis to resistance against immune checkpoint inhibitors, including impaired efficacy of anti-PD-1/PD-L1 therapies when gut microbial homeostasis is disrupted.",{"name":119,"@type":110,"acceptedAnswer":120},"What roles do microbial biomarkers and microbiota-targeted interventions play?",{"text":121,"@type":113},"The review highlights microbial signatures as predictive biomarkers for disease and therapy response, and discusses interventions such as probiotics and fecal microbiota transplantation to modulate microbial composition and enhance antitumor immunity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366523,1790505874,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Review  \nPUBLISHED 20 August 2025  \nDOI 10.3389/fmicb.2025.1606684  \nOPEN ACCESS  \nEDITED BY  \nJinbo Xiong,  \nNingbo University, China  \nREVIEWED BY  \nJoyeeta Talukdar,  \nAll India Institute of Medical Sciences, India Dorota Pastuszak-Lewandoska,  \nMedical University of Lodz, Poland  \n*CORRESPONDENCE  \nWen-Tao Hu  \n [34836674@qq.com](34836674@qq.com)[ ](34836674@qq.com)Zhi-Gang Liang  \n [39908517@qq.com](39908517@qq.com)[ ](39908517@qq.com)RECEIVED 07 April 2025 ACCEPTED 11 August 2025 PUBLISHED 20 August 2025  \nCITATION  \nShi M, Wang L-F, Hu W-T and Liang Z-G (2025) The gut microbiome in lung cancer:  \nfrom pathogenesis to precision therapy. Front. Microbiol. 16:1606684 .  \ndoi: 10.3389/fmicb.2025.1606684  \nCOPYRIGHT  \n© 2025 Shi, Wang, Hu and Liang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe gut microbiome in lung cancer: from pathogenesis to precision therapy  \nMiao Shi, Long-Fei Wang, Wen-Tao Hu * and Zhi-Gang Liang * Department of Thoracic Surgery, First Affiliated Hospital of Ningbo University, Ningbo, China  \nThe gut microbiome has emerged as a key modulator of immune responses and treatment efficacy in oncology. Growing evidence links gut dysbiosis to resistance against immune checkpoint inhibitors (ICIs) in advanced cancers, prompting exploration of the gut-lung axis—a bidirectional network connecting intestinal microbiota with pulmonary health. Given lung cancer’s status as the leading cause of cancer mortality worldwide, understanding this axis holds significant therapeutic potential. This review synthesizes current knowledge on gut microbiota’s role in lung cancer development, diagnosis, and treatment. We highlight microbial signatures predictive of disease and therapy response, discuss microbiota-targeted interventions (e. g., probiotics, Fecal Microbiota Transplantation), and elucidate mechanistic insights into microbial-immune crosstalk. Finally, we outline future directions for leveraging the gut microbiome in personalized lung cancer management.  \nKEYWORDS  \ngut microbiome, gut-lung axis, lung cancer, immunotherapy, microbial biomarkers  \n1 Introduction  \nLung cancer maintains its position as the leading cause of cancer-related mortality worldwide, accounting for approximately 2.2 million new cases and 1.8 million deaths annually (Sung et al., 2021) . Histologically, lung cancer is broadly classified into small cell lung carcinoma and non-small cell lung carcinoma (NSCLC), with the latter accounting for over 85% of all cases (Sung et al., 2021) . Globally, the most common histological subtypes of NSCLC are adenocarcinoma (40%) and squamous cell carcinoma (25%) (Su et al., 2025) . Smoking is a well-established risk factor for lung cancer, while other risk factors include lifestyle and environmental exposures such as biomass fuel exposure, occupational hazards, and air pollution (Leiter et al., 2023) . Additionally, genetic predisposition and gender are significant risk factors that cannot be overlooked (Jemal et al., 2018) . Despite therapeutic advancements including radiotherapy, chemotherapy, immunotherapy, and surgical interventions, clinical outcomes remain suboptimal, with persistently low survival rates and substantial treatment-related toxicities underscoring the urgent need for innovative approaches (Lahiri et al., 2023). In this context, the conceptual framework of the “gut-lung axis” has gained considerable traction, proposing a sophisticated bidirectional communication network between intestinal microbiota and pulmonary physiology mediated through integrated immune, neural, and metabolic pa","cbCairIuBDYpAekv","https://ap.wps.com/l/cbCairIuBDYpAekv","pdf",277733,"English","# Introduction\n## Gut-lung axis and immune modulation\n## Gut dysbiosis and resistance to immune checkpoint blockade\n## Gut microbiota-targeted therapeutic directions","[{\"question\":\"What is the gut-lung axis and why is it relevant to lung cancer?\",\"answer\":\"The gut-lung axis is described as a bidirectional network connecting intestinal microbiota with pulmonary physiology through immune, neural, and metabolic pathways, enabling systemic immunomodulatory effects relevant to lung cancer development and treatment.\"},{\"question\":\"How can gut dysbiosis affect immunotherapy outcomes in lung cancer?\",\"answer\":\"The document links gut dysbiosis to resistance against immune checkpoint inhibitors, including impaired efficacy of anti-PD-1/PD-L1 therapies when gut microbial homeostasis is disrupted.\"},{\"question\":\"What roles do microbial biomarkers and microbiota-targeted interventions play?\",\"answer\":\"The review highlights microbial signatures as predictive biomarkers for disease and therapy response, and discusses interventions such as probiotics and fecal microbiota transplantation to modulate microbial composition and enhance antitumor immunity.\"}]","The gut microbiome in lung cancer - from pathogenesis to precision therapy | PDF",1790165944,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b73d80e1b6fe0ba45105595aa812d617.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76628546dc18a2237e97c5d37195beb9.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3212827f3ab144cf121535dd69c0c694.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69f8df97588fd332fe4d4ec1edcaf75e.webp",980,1385]